跳至主要内容
临床试验/ACTRN12618000409279
ACTRN12618000409279进行中(未招募)未知

The effect of enteral glycine on plasma glycine and muscle histopathology, structure and function in the critially ill

Royal Melbourne Hospital0 个研究点目标入组 29 人开始时间: 2018年3月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • a.Aged 18 years or over
  • b.Receiving invasive mechanical ventilation and expected to remain mechanically ventilated until the day after tomorrow
  • c.Arterial or central venous line in situ
  • d.Receiving or suitable to receive EN
  • e.Expected to be receiving EN in the ICU until at least the day after tomorrow

排除标准

  • a.Death during ICU admission deemed to be inevitable
  • b.Pregnancy
  • c.Lower limbs amputated
  • d.Spinal cord injury
  • e.Presented with primary neuromuscular pathology
  • f.Presented with disseminated cancer
  • g.Bleeding diathesis (corrected INR > 1.5 and/or APTT > 50), or receiving anticoagulants beyond that required for venous thromboembolism prophylaxis or antiplatelet drugs other than aspirin
  • h.Received > 72 hours of EN or PN during this ICU admission
  • i.Intolerant of EN (gastric residual volume > 300mL)
  • j.Already been admitted to ICU for > 96 hours during this hospitalization
  • k.Previously enrolled in this study
  • l.Requirement for specific nutritional therapy as determined by the treating doctor or dietitian

研究者

相似试验

Is glycine absorbed in critical illness and can it... | 临床试验